Ligand Pharmaceuticals News
Most Popular Ligand Pharmaceuticals Story
GSK relying on Ph3 strategy in R&D comeback bid
GlaxoSmithKline ($GSK) was one of the first of the Big Pharma companies to concede that its R&D effort needed to be completely revamped. Over the last couple of years GSK responded by breaking Read more...
Latest Headlines
- July 26, 2011
- March 25, 2011
- January 27, 2011
- November 24, 2010
- October 27, 2009
- August 25, 2009
- March 25, 2009
- February 9, 2009
- December 18, 2008
- November 21, 2008
- September 25, 2008
- September 9, 2008
- June 2, 2008
- May 28, 2008
- July 26, 2007
- January 31, 2007
- January 16, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
